Intent to Sole Source - 2 BK Medical E14CL4b Biplane Endocavity transducer Transrectal and Transvaginal probes
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institute of Health (NIH) has issued an Intent to Sole Source for the urgent procurement of 2 BK Medical E14CL4b Biplane Endocavity transducer Transrectal and Transvaginal probes. NIH intends to negotiate with GE Precision Healthcare LLC (BK Medical Holding Company, Inc.). This is not a request for proposal, but interested parties may submit capability statements by March 6, 2026, at 12:00 PM EST.
Purpose & Scope
NIH requires these probes to support Dr. Pinto and Dr. Woods' prostate biopsy fusion cases, enabling multiple procedures to be performed daily. The E14CL4b probe is an upgrade, offering improved image quality and ease of use. The increased need is also driven by sterile processing transitioning to a new space, requiring more probes to manage turnover times between cases.
Contract Details
- Type: Special Notice / Intent to Sole Source
- Authority: 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (only one responsible source).
- Intended Vendor: GE Precision Healthcare LLC (BK Medical Holding Company, Inc.)
- Place of Performance: Bethesda, MD 20892, United States
- Product Service Code: 1190 - Specialized Test And Handling Equipment, Nuclear Ordnance
Set-Aside
None specified.
Response & Deadlines
This is not a Request for Proposal. However, all responsible sources capable of providing the required probes may submit a capability statement via email to valerie.gregorio@nih.gov. The subject line must reference "NOI-OLAO-26-003897".
- Capability Statement Due: March 6, 2026, at 12:00 PM Eastern Standard Time.
- Published Date: March 4, 2026.
Additional Notes
The Government will consider all responses received by the closing date. A determination not to compete this requirement, based on responses, is solely at the Government's discretion.